home / stock / mbio / mbio news

MBIO News and Press, Mustang Bio Inc. From 03/16/20

Stock Information
Company Name: Mustang Bio Inc.
Stock Symbol: MBIO
Market: NASDAQ
Website: mustangbio.com
Menu
MBIO MBIO Quote MBIO Short MBIO News MBIO Articles MBIO Message Board
Get MBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
MBIO - Mustang Bio EPS misses by $0.15

Mustang Bio (NASDAQ: MBIO ): FY GAAP EPS of -$1.29 misses by $0.15 . More news on: Mustang Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MBIO - Mustang Bio Reports Full-Year 2019 Financial Results and Recent Corporate Highlights

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...

MBIO - Mustang Bio Announces First Subject Treated in Phase 1/2 Trial with the Optimized CD20-targeted CAR T Cell Therapy MB-106

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumor...

MBIO - Mustang Bio to Present at the Phacilitate Leaders World & World Stem Cell Summit 2020

NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumor...
MBIO - Mustang Bio down 18% on less effect of gene therapy on older XSCID patients

Thinly traded Mustang Bio ( MBIO -17.7% ) is down on almost 4x higher volume, albeit on turnover of less than 1M shares, in apparent reaction to updated data from ongoing Phase 1/2 clinical trials evaluating lentiviral gene therapy MB-107 in patients with X-linked severe combined immunod...

MBIO - AR, ARQL, MBIO and DPLO among midday movers

Gainers: Synthorx (NASDAQ: THOR )  +170% . More news on: Synthorx, Inc., ArQule, Inc., Forty Seven, Inc., Stocks on the move, Read more ...

MBIO - Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency

MB-107 preceded by low-dose busulfan conditioning continues to be well tolerated and results in development of functional immune system in newly diagnosed infants with XSCID Enhanced transduction procedure is demonstrating improvements in older patients with XSCID who received prior he...
MBIO - Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference

NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumor...

MBIO - Cantor sees 19% upside in J&J in premarket analyst action

Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Outperform rating and $128 (31% upside) price target at Oppenheimer. More news on: Alnylam Pharmaceuticals, Inc., Amarin Corporation plc, CytomX Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

MBIO - Mustang Bio EPS beats by $0.01

Mustang Bio (NASDAQ: MBIO ): Q3 GAAP EPS of -$0.25 beats by $0.01 . More news on: Mustang Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10